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A B S T R A C T
Systemic necrotizing vasculitides preferentially involve small- or medium-sized ves-
sels and occasionally the coronary vessels and the myocardium. Cardiac involvement 
was noninvasively evaluated in a group of 32 patients with vasculitides but without 
cardiac symptoms with use of magnetic resonance imaging techniques and compared 
with a control group of 13 individuals. The study showed increased coronary vessel 
diameters in the majority of patients and in some patients to the degree of ectasia; 
myocardial scar was rare.
Vasculitides constitute a heterogeneous group of disorders affecting from large 
arteries to post-arteriolar capillaries. These disorders can affect all organs and are 
categorized on the basis of the affected artery diameter and the presence or absence 
of antibodies to neutrophil cytoplasmic antigens (ANCA). ANCA-positive vasculiti-
des involve small to medium size arteries of many organs, primarily of the upper and 
lower respiratory system, the kidneys and the peripheral nervous system. Microscopic 
polyangiitis (MPA), Wegener granulomatosis (WG) and Churg-Strauss syndrome 
(CS) are forms of these vasculitides.1 Coronary arteries have been previously shown 
to be occasionally affected during the course of these diseases; however, this has never 
been formally assessed.
To evaluate non-invasively the coronary arteries of patients with ANCA-positive 
vasculitides, magnetic resonance angiography (MRA) was perfomed and the viability 
was studied using contrast-enhanced MRI (ceMRI).2 Twelve patients with MPA, 13 
with WG, 5 with CS and 2 with polyarteritis nodosa (PAN), all without any cardiac 
symptoms were included in the study and compared with 13 age- and sex-matched 
healthy controls and with a disease control group of 13 patients with rheumatoid 
arthritis (RA). The maximal diameter of the proximal one third of each coronary 
vessel was recorded. MRA was performed using a 1.5 Tesla system. Data acquisition 
was performed with ECG gating in mid-diastole and with the patient breathing freely. 
ceMRI images were acquired 15 minutes after the IV injection of 0.15 mmol/kg gado-
linium-diethylene triamine pentaacetic acid (Gd-DTPA) using an inversion recovery 
gradient echo pulse sequence.
As shown in the table (Table 1), the diameter of all coronary arteries tested were 
found significantly increased in patients with MPA, PAN and WG (p<0.001 for LAD 
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and RCA, p<0.01 for LCx) compared to controls, but not 
in those with CS. Criteria for ectasia were fulfilled by MPA 
and PAN patients, but not WG. The comparison of coronary 
vessel diameters revealed increased coronary artery diameter 
in the MPA+PAN patient group compared to that of WG 
(p<0.05 for LAD and LCx, p<0.01 for RCA). Coronary vessel 
diameters were increased in the MPA+PAN group compared 
to RA (p<0.01 for LAD and RCA and p<0.05 for LCx), but 
there was no difference between WG or CS and RA. Evidence 
of myocardial scar in Gd-DTPA images was documented in 1 
patient with MPA and in 1 patient with CS.
In conclusion, coronary artery ectasia appears a common 
finding in asymptomatic vasculitis patients, while scar is rare. 
Magnetic resonance imaging3 evaluation is feasible in these 
forms of vasculitis and may prove of value for treatment 
guidance.
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TABLE 1. Coronary vessel diameters (mean ± SD) in patients and controls
Coronary vessel MPA+PAN * WG * CS RA Healthy controls
LAD (mm) 4.58 ±1.27 3.57 ±0.69 2.66 ±0.51 3.06 ±0.60 3.05 ±0.15
RCA (mm) 4.68 ±1.00 3.55 ±0.92 2.68 ±0.77 3.27 ±0.81 3.17 ±0.20
LCx (mm) 4.01 ±1.16 3.16 ±0.45 2.48 ±0.73 3.20 ±0.56 3.08 ±0.19
* P <0.01 vs controls
CS= Churg-Strauss syndrome; LAD= left anterior descending (coronary artery); LCx= left circumflex; MPA= microscopic polyangiitis; PAN= 
polyarteritis nodosa; RA= rheumatoid arthritis; RCA= right coronary artery; WG= Wegener’s granulomatosis
